Therefore, Sal, or D4476, is an NRF2 inhibitor and is involved in anti-colorectal cancer effects via the crosstalk between the p62-NRF2 pathway and autophagy, which may provide novel insights into therapeutic directions for colorectal cancer based on the anti-oxidant response during tumor progression. This evidence concerns the gene SQSTM1 and neoplasm.